Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Biol Ther. 2002 Oct;2(7):741-9.

New tuberculosis vaccine development.

Author information

1
Sequella, Inc., 9610 Medical Center Drive, Suite 200, Rockville, MD 20850, USA.

Abstract

Tuberculosis (TB) is a devastating disease that kills more than three million people each year. Of these, 0.9 million are co-infected with HIV and numbers of infections and death continue to rise with the global spread of HIV. A new vaccine is desperately needed to control this epidemic that threatens to kill 90 million people over the next 3 decades. Outstanding work in research laboratories, combined with the success of genome sequencing, has resulted in a variety of candidate TB vaccines, many of which are sufficiently promising to advance into clinical trials. This review discusses the array of new candidate TB vaccines and the clinical studies that are currently planned.

PMID:
12387673
DOI:
10.1517/14712598.2.7.741
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center